Edition:
United States

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

5.95USD
15 Jun 2018
Change (% chg)

$0.01 (+0.17%)
Prev Close
$5.94
Open
$5.95
Day's High
$6.00
Day's Low
$5.57
Volume
5,251
Avg. Vol
4,705
52-wk High
$6.00
52-wk Low
$2.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jan '18 5.08 0.630
Oct 5.20 -0.009
Jul 5.03 -0.061
FY 2017 Apr '17 3.72 -0.196
Jan '17 3.57 -0.128
Oct 4.46 -0.046
Jul 3.67 -0.259
FY 2016 Apr '16 2.84 -0.297
Jan '16 2.55 -0.277
Oct 2.97 -0.293
Jul 2.82 -0.335
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 16.37 240.92 34.18
P/E High - Last 5 Yrs. -- 292.40 47.65
P/E Low - Last 5 Yrs. -- 101.52 25.16
Beta -0.12 0.73 0.78
Price to Sales (TTM) 3.44 277.70 8.57
Price to Book (MRQ) 138.77 23.83 4.35
Price to Tangible Book (MRQ) -- 31.28 6.03
Price to Cash Flow (TTM) 16.13 141.17 22.78
% Owned Institutions 40.09 10.77 2.40

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 2.24 -6.56
Payout Ratio(TTM) 0.00 42.16 39.28

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 42.55 24.66 5.00
Sales (TTM) vs TTM 1 Yr. Ago 31.03 138.03 12.50
Sales - 5 Yr. Growth Rate 16.60 30.82 7.91
EPS (MRQ) vs Qtr. 1 Yr. Ago 590.21 -77.30 40.63
EPS (TTM) vs TTM 1 Yr. Ago 149.79 -- --
EPS - 5 Yr. Growth Rate -- 48.49 8.03
Capital Spending - 5 Yr. Growth Rate 8.10 36.28 7.42

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.67 2.56
Current Ratio (MRQ) 0.68 6.39 3.64
LT Debt to Equity (MRQ) 4.87 20.82 12.92
Total Debt to Equity (MRQ) 10.38 25.11 17.37
Interest Coverage (TTM) -- -142.62 35.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 45.69 56.39 54.96
Gross Margin - 5 Yr. Avg. 36.84 54.91 52.86
EBITD Margin (TTM) -14.80 -- --
EBITD - 5 Yr. Avg -75.71 -171.18 15.70
Operating Margin (TTM) -16.52 -947.86 -0.76
Operating Margin - 5 Yr. Avg. -77.43 -184.89 10.94
Pre-Tax Margin (TTM) -17.01 -831.06 1.32
Pre-Tax Margin - 5 Yr. Avg. -79.42 -188.29 11.12
Net Profit Margin (TTM) 19.60 -824.15 -1.97
Net Profit Margin - 5 Yr. Avg. -79.90 -186.71 7.48
Effective Tax Rate (TTM) -- 15.20 29.90
Effective Tax Rate - 5 Yr. Avg. -- 19.22 24.12

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 21,950,230 736,829,609
Net Income/Employee (TTM) -- -523,802 85,814,668
Receivable Turnover (TTM) 7.66 18.22 6.06
Inventory Turnover (TTM) -- 2.86 3.65
Asset Turnover (TTM) 2.60 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 50.98 -3.98 10.37
Return on Assets - 5 Yr. Avg. -96.50 -1.14 11.09
Return on Investment (TTM) 233.83 -5.87 13.17
Return on Investment - 5 Yr. Avg. -179.32 1.58 14.39
Return on Equity (TTM) 297.13 -7.71 15.15
Return on Equity - 5 Yr. Avg. -212.42 -3.84 15.73
  1 Year 3 Year 5 Year
Sales % 37.82 10.09 16.60
EPS (TTM) % 46.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Champions Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.09%
# of Holders: 16
Total Shares Held: 4,410,779
3 Mo. Net Change: 111,243
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 5
# Reduced Positions: 8
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.